According to the research report titled ‘North America Ambulatory Surgical Centers Market Statistics By Surgery Type, Ownership, Specialty Type, Service, Country Outlook, Industry Forecast, 2018 – 2024’, available at MarketStudyReport.com, the North America ambulatory surgical centers market is expected to surpass USD 35 billion by the year 2024.
 

As per the report, rising elderly population could be a major factor driving North America ambulatory surgical centers industry growth. Nowadays, baby boomers are becoming more vulnerable to diseases due to functional and anatomic changes. In addition to this, there is an increasing pervasiveness of chronic diseases among elderly population, fostering the demand for ambulatory surgical centers (ASCs) across North America.
 

The region is also recording rising demand for minimally invasive treatment methods that offer benefits such as less scarring, injury to tissue, pain and shorter stay at hospitals. Availability of advanced surgical technology in ambulatory surgical centers for non-invasive treatment may stimulate ASC industry outlook. However, high cost associated with medical devices and low patient-to-physician ratio may hinder market size.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2506000/
 

By ownership, in 2017, the physicians owned segment held for about 50% revenue share in North America ambulatory surgical centers, and is presumed to expand substantially over the coming years. Shifting preferences towards cost effective treatment options that are offered by physicians owned ambulatory surgical centers may propel segment size.
 

As per surgery type, the ophthalmic segment is expected to register significant growth during the estimated timeframe. In 2017, the segment was reported to be worth USD 4.9 billion. Increasing cataract surgeries conducted in ambulatory surgical centers along with rising prevalence of diabetes in North America is supporting segment growth.
 

Based on specialty type, the single-specialty segment may witness 4.9% CAGR over the estimated timeframe. Single-specialty ASCs offer cost-effective procedures and require comparatively less resources.
 

Elaborating on service type, the treatment segment is predicted to generate USD 28 billion by the year 2024. Growing demand for high-quality healthcare at inexpensive cost could bolster the treatment segment expansion. Meanwhile, escalating healthcare expenditure and growing demand for advanced treatment options may accelerate treatment service segment share in North America ASC market.
 

Considering the geographical landscape, U.S. ambulatory surgical centers industry is set to record 4.5% growth through 2024. Technological advancements and rising presence of ambulatory surgical centers will positively influencing industry outlook. Furthermore, favorable reimbursement policies and availability of minimally invasive treatment methods may augment the demand for ambulatory surgical centers in the U.S.
 

Some of the prominent companies operating in North America ambulatory surgical centers industry include Tenet Healthcare, AMSURG (Envision Healthcare Solution), Covenant Surgical Partners, Surgical Care Affiliates, SurgCenter Development, Surgery Partners, Regent Surgical Health, Proliance Surgeons, Physicians Endoscopy, HCA Healthcare, Surgical Management Professionals, ASD Management, and Ambulatory Surgical Centers of America.